• PDF / 169,156 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 92 Downloads / 155 Views

DOWNLOAD

REPORT

---

1 S

Neutropenia: case report In a retrospective analysis of 96 patients who underwent treatment at a hospital in China between January 2018 and October 2019, a patient [age and sex not stated] was described, who developed neutropenia during treatment with cyclophosphamide and epirubicin for breast cancer. The patient with breast cancer, received treatment with cyclophosphamide and epirubicin [routes and dosages not stated] and developed grade 3–4 neutropenia after cycle 1 [outcome not stated]. The patient received prophylactic pegfilgrastim [Jinyouli] during subsequent cycles; the patient’s chemotherapy was delayed. Chong X, et al. Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor in the prevention of chemotherapyinduced neutropenia in patients with breast cancer. Journal of Clinical Oncology 38: abstr. e12515, No. 15, Jan 2020. Available from: URL: https://ascopubs.org/doi/abs/10.1200/ 803505193 JCO.2020.38.15_suppl.e12515 [abstract]

0114-9954/20/1824-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 3 Oct 2020 No. 1824